$QTRX News

Canaccord Genuity Maintains Hold on Quanterix, Lowers Price Target to $3

Quanterix: The Market Was Right To Lose Patience (Rating Downgrade)

TD Cowen Maintains Hold on Quanterix, Lowers Price Target to $3

Quanterix Corporation 2026 Q2 - Results - Earnings Call Presentation

Quanterix Corporation (QTRX) Q2 2026 Earnings Call Transcript

CORRECTION: Quanterix Q2 Adj. EPS $(0.47) Misses $(0.46) Estimate, Sales $32.906M Miss $37.462M Estimate

Quanterix Q2 EPS $(1.04) Misses $(0.40) Estimate, Sales $32.906M Miss $37.462M Estimate

Quanterix Lowers FY2026 Sales Guidance from $169.000M-$174.000M to $142.000M-$148.000M vs $169.930M Est

Quanterix Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages

Quanterix Announces Milestones Advancing Clinical Adoption Of Blood-Based Alzheimer's Testing

Quanterix (QTRX) Stock Fair Value Falls After Analysts Cut Price Targets

Quanterix Stock Is Popping In Pre-Market: Here's Why

TRIB, QTRX, RCON: Why These Stocks Are Surging After-Hours Today

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quanterix Corporation (QTRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer

Quanterix Appoints Jason Faessler CFO, Effective June 22

Quanterix Appoints Industry Veteran Geoff Albrecht as Senior Vice President and General Manager of Diagnostics

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)